Adjuvant therapy of breast cancer /
Saved in:
| Imprint: | Boston : Kluwer Academic Publishers, 1992. |
|---|---|
| Description: | xvi, 464 p. : ill. ; 25 cm. |
| Language: | English |
| Series: | Cancer treatment and research ; 60 Cancer treatment and research v. 60. |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/1393709 |
Table of Contents:
- I. Rationale and Methods for Studying Adjuvant Systemic Therapy. 1. Evolving concepts in the adjuvant systemic therapy of operable breast cancer / L. Norton. 2. Statistical methods for early breast cancer trials / R. Gelman
- II. Results of Clinical Studies. 3. The nature of the benefit / I.C. Henderson. 4. Adjuvant endocrine therapy of breast cancer / M.E. Trudeau and K.I. Pritchard. 5. Adjuvant chemotherapy of axillary lymph-node-positive breast cancer / N.E. Davidson and Martin D. Abeloff. 6. The node-negative problem: To treat or not to treat / D.L. Ahmann
- III. Special Problems. 7. Defining the high-risk breast cancer patient / G.M. Clark and W.L. McGuire. 8. Models for weighing benefits and toxicities / R.D. Gelber and A. Goldhirsch. 9. Financial considerations in the use of adjuvant chemotherapy / R.J. Irvin and J.G. Kuhn. 10. The use of adjuvant therapy in patients treated with conservative surgery and radiotherapy / A. Recht, D.F. Hayes and J.R. Harris. 11. Treating the relapsed patient / R.T. Chlebowski
- IV. Future Directions. 12. Unanswered questions in the adjuvant therapy of breast cancer / F.A. Dorr and M.A. Friedman. 13. Neoadjuvant chemotherapy / W.C. Wood. 14. Altering cell kinetics with endocrine therapy / R. Paridaens. 15. Polypeptide growth factors: Their potential value in the management of breast cancer patients / C.K. Osborne. 16. Immunotherapy of breast cancer / J.B. Breitmeyer. 17. Breast cancer chemoprevention / U. Veronesi and A. Costa
- App. I. Consensus statements from panels convened by The National Cancer Institute in 1980, 1985, 1990
- App. II. List of completed and ongoing randomized clinical trials addressing questions related to the use of adjuvant systemic therapy to treat resectable breast cancer.
